Provepharm Inc. recalls Dihydroergotamine Mesylate Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Discoloration
- Products
-
- Dihydroergotamine Mesylate Injection
- Company
- Provepharm Inc.
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 2160 packs/5 ampules per pack = 10,800 ampules
- About this recall
- Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05